OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Funded proposals will advance science to restore sight and prevent blindness through donation, transplantation, and research.

Scheicho Scheifa is haunted by the fear of going blind. A disease called trachoma has turned his eyelids inwards, causing his eyelashes to scar his corneas so badly that one has already turned opaque.

Optic neuritis: optic nerve swelling can cause painful eye movement and temporary vision loss. Toxic scleritis: a ...

This means rural residents with eye problems often face a long drive to get the care they need. For example, “our results ...

Sure, you might be the ultimate staring contest winner if you stop blinking but there'd be consequences to face ...

A seemingly harmless nap turned into a life-changing ordeal for a Florida man who lost vision in one eye after sleeping with ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

They report a case of endophthalmitis and undertook a literature review to identify previous infections with this pathogen.

DATROWAY ® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

SightMD Connecticut is pleased to announce its acquisition of Doctor & Associates, a trusted provider of advanced eye care services in Fairfield County since 1965. This strategic partnership marks a ...